Sign up to save your podcasts
Or
Share Psychedelics, Hospice & the Law: What Physicians Need to Know
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Psychedelics, Hospice & the Law: What Physicians Need to Know
What if relief from end-of-life suffering already exists… but patients can't legally access it?
In this episode of Too Curious MDs, lawyer and end-of-life care advocate Kathryn L. Tucker explores the legal barriers surrounding psychedelic-assisted therapy, particularly for patients facing serious and terminal illness. Drawing from decades of advocacy in end-of-life care, she explains how federal scheduling laws, regulatory delays, and limited legal pathways continue to restrict access despite growing clinical evidence.
The conversation breaks down what physicians can safely discuss with patients, the difference between education and participation, and the emerging pathways patients are using today, including clinical trials, state programs, and international retreats. It also highlights ongoing advocacy efforts, including rescheduling petitions and federal legislation, aimed at creating a legal framework that aligns with the science and supports compassionate care.
- - - - -
About the Guest:
Kathryn L. Tucker, JD, is a leading legal advocate at the intersection of medical decision-making, end-of-life care, and therapeutic access. With over 35 years of experience, she has played a pivotal role in advancing patient rights, including landmark work in death with dignity legislation and expanding care options for those with serious and terminal illness.
Her recent work focuses on creating legal pathways for access to psychedelic-assisted therapies, particularly for patients experiencing anxiety and depression at the end of life. Through litigation, policy advocacy, and national initiatives, she continues to push for alignment between emerging science and compassionate care.
- - - - -
Social Handles:
Website: https://www.cascadianow.org/end-of-life-liberty-project
LinkedIn: https://www.linkedin.com/in/kathrynlt
- - - - -
Dr. Alya Ahmad, MD, FAAP
LinkedIn: https://www.linkedin.com/in/alya-ahmad-md-0601b190/
Instagram: https://www.instagram.com/shamynds/
Facebook: https://www.facebook.com/shamynds
Website: https://shamynds.com/
Dr. Suraiya Simi Rahman, MD, FAAP
Website: https://palamedicine.com/
Linkedin: https://www.linkedin.com/in/suraiya-rahman-palamedicine/
Instagram: https://www.instagram.com/pala_medicine/
Facebook: https://www.facebook.com/palamedicine.pasadena/
Too Curious MDs
Instagram: https://www.instagram.com/toocuriousmds?igsh=NTc4MTIwNjQ2YQ%3D%3D&utm_source=qr
YouTube: https://www.youtube.com/@TooCuriousMDs
- - - - -
PODCAST
Thank you for listening.
Please subscribe and share.
This podcast is produced by DrTalks.com
https://drtalks.com/podcast-service/
View all episodes
By Too Curious MDsWhat if relief from end-of-life suffering already exists… but patients can't legally access it?
In this episode of Too Curious MDs, lawyer and end-of-life care advocate Kathryn L. Tucker explores the legal barriers surrounding psychedelic-assisted therapy, particularly for patients facing serious and terminal illness. Drawing from decades of advocacy in end-of-life care, she explains how federal scheduling laws, regulatory delays, and limited legal pathways continue to restrict access despite growing clinical evidence.
The conversation breaks down what physicians can safely discuss with patients, the difference between education and participation, and the emerging pathways patients are using today, including clinical trials, state programs, and international retreats. It also highlights ongoing advocacy efforts, including rescheduling petitions and federal legislation, aimed at creating a legal framework that aligns with the science and supports compassionate care.
- - - - -
About the Guest:
Kathryn L. Tucker, JD, is a leading legal advocate at the intersection of medical decision-making, end-of-life care, and therapeutic access. With over 35 years of experience, she has played a pivotal role in advancing patient rights, including landmark work in death with dignity legislation and expanding care options for those with serious and terminal illness.
Her recent work focuses on creating legal pathways for access to psychedelic-assisted therapies, particularly for patients experiencing anxiety and depression at the end of life. Through litigation, policy advocacy, and national initiatives, she continues to push for alignment between emerging science and compassionate care.
- - - - -
Social Handles:
Website: https://www.cascadianow.org/end-of-life-liberty-project
LinkedIn: https://www.linkedin.com/in/kathrynlt
- - - - -
Dr. Alya Ahmad, MD, FAAP
LinkedIn: https://www.linkedin.com/in/alya-ahmad-md-0601b190/
Instagram: https://www.instagram.com/shamynds/
Facebook: https://www.facebook.com/shamynds
Website: https://shamynds.com/
Dr. Suraiya Simi Rahman, MD, FAAP
Website: https://palamedicine.com/
Linkedin: https://www.linkedin.com/in/suraiya-rahman-palamedicine/
Instagram: https://www.instagram.com/pala_medicine/
Facebook: https://www.facebook.com/palamedicine.pasadena/
Too Curious MDs
Instagram: https://www.instagram.com/toocuriousmds?igsh=NTc4MTIwNjQ2YQ%3D%3D&utm_source=qr
YouTube: https://www.youtube.com/@TooCuriousMDs
- - - - -
PODCAST
Thank you for listening.
Please subscribe and share.
This podcast is produced by DrTalks.com
https://drtalks.com/podcast-service/